8月25日,和黄医药发布公告,其执董事苏慰国博因健康理由将暂停履行执官的职务。执董事兼首席财务官郑泽锋先担任代理首席执行官职,即时效。 苏慰国在哈佛大学取得博士学位并从事博士后研究,2005年加入和黄医药,2012年起担任首席科学官,2017年起担任公司执行董事,2022年3月4日起担任首席执行官。加入和黄医药以来,苏慰国博士带领团队进行药物的发现及研究。 郑泽锋2008年起担任和黄医药首席...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.